1. COMBATing Breast Cancer Conference

Abstracts (HTML) Autorenliste

Bacchus, L.

Endocrine Therapy: Translational Research on CYP2D6 Genetics for Tamoxifen Response in Breast Cancer

Brauch, H.

Endocrine Therapy: Translational Research on CYP2D6 Genetics for Tamoxifen Response in Breast Cancer

Brockhoff, G.

Novel aspects in endocrine treatment of breast cancer

Buchholz, S.

Novel aspects in endocrine treatment of breast cancer

Bürger, H.

Basal, luminal and myoepithelial cells: immunophenotypical and molecular characterization

Dittmer, J.

Communication between epithelial and stromal cells

Eichelbaum, M.

Endocrine Therapy: Translational Research on CYP2D6 Genetics for Tamoxifen Response in Breast Cancer

Fehm, T.

Impact of Disseminated Tumor Cells in Bone Marrow and Circulating Tumor Cells in the Blood of Breast Cancer Patients

Gluz, O.

Resistance to chemotherapy

Harbeck, N.

Molecular basis and possibilities for modulation of resistance to anti-HER2 therapy

Holst, F.

ESR1 amplification in breast cancer – A new predictive marker?

Jacobs, V. R.

Cost planning for oncological therapies from the clinic's point of view regarding clinical care and studies [Kostenplanung onkologischer Therapien aus Sicht der Klinik im Rahmen klinischer Versorgung und Studien]

Janni, W.

Impact of Disseminated Tumor Cells in Bone Marrow and Circulating Tumor Cells in the Blood of Breast Cancer Patients

Kaufmann, M.

Breast Cancer, inflammation and proliferation

Liedtke, C.

Triple negative breast cancer – molecular basics and clinical impact

Mattheß, Y.

Breast Cancer, inflammation and proliferation

Minckwitz, G. von

Clinical testing of new molecular agents – do we have a clinical trial problem?

Müller, V.

Impact of Disseminated Tumor Cells in Bone Marrow and Circulating Tumor Cells in the Blood of Breast Cancer Patients

Ortmann, O.

Novel aspects in endocrine treatment of breast cancer

Pantel, K.

Impact of Disseminated Tumor Cells in Bone Marrow and Circulating Tumor Cells in the Blood of Breast Cancer Patients

Poremba, C.

Molecular and phenotypic changes in the mammary gland in different phases of life: Puberty, pregnancy and menopause

Raab, M.

Breast Cancer, inflammation and proliferation

Reimer, T.

Antiangiogenic therapy: the problem of redundant pathways

Rody, A.

The Cancer Stem-Cell Hypothesis of Breast Cancer

Rüschoff, J.

The Role of Her-2 in the Carcinogenesis of Breast Cancer – When and Where?

Schneeweiss, A.

Molecular techniques for identification of new prognostic and predictive markers

Schroth, W.

Endocrine Therapy: Translational Research on CYP2D6 Genetics for Tamoxifen Response in Breast Cancer

Schwab, M.

Endocrine Therapy: Translational Research on CYP2D6 Genetics for Tamoxifen Response in Breast Cancer

Simon, W.

Endocrine Therapy: Translational Research on CYP2D6 Genetics for Tamoxifen Response in Breast Cancer

Spänkuch, B.

„Gene therapy“: from bench to bedside?

Stickeler, E.

Pathophysiology of EGFR and options of targeting

Strebhardt, K.

Breast Cancer, inflammation and proliferation

Treeck, O.

Novel aspects in endocrine treatment of breast cancer

Wülfing, P.

Angiogenesis/tumor hypoxia: new treatment options?

Yu-Poth, S.

Clinical and Molecular Parameters to Predict Therapy Response